$18.43
+3.6%Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
Last Annual Value
12.96M
3-Year CAGR
25%
5-Year CAGR
14%
10-Year CAGR
7%
| Company | Stock Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Omada Health NASDAQ:OMDA | 12.96M | 14.0% | N/A | N/A | |
![]() Omnicell, Inc. NASDAQ:OMCL | 44.50M | -7.0% | -3.5% | 8.6% | |
![]() BioCryst Pharmaceuticals, Inc. NASDAQ:BCRX | 0.00 | N/A | N/A | N/A | |
![]() 10x Genomics, Inc. NASDAQ:TXG | 109.12M | -13.2% | 2.6% | N/A | |
![]() Maze Therapeutics, Inc. NASDAQ:MAZE | 16.40M | 23.3% | N/A | N/A | |
![]() Xeris Biopharma Holdings, Inc. NASDAQ:XERS | 22.37M | 27.8% | 14.5% | 45.1% | |
![]() Teladoc Health, Inc. NYSE:TDOC | 80.41M | -26.4% | N/A | 26.4% | |
![]() UFP Technologies, Inc. NASDAQ:UFPT | 8.85M | 24.0% | 29.5% | 23.7% | |
![]() Progyny, Inc. NASDAQ:PGNY | 131.87M | 2.5% | N/A | N/A | |
![]() Phreesia, Inc. NYSE:PHR | 67.45M | 4.7% | 38.0% | N/A | |
![]() Schrödinger, Inc. NASDAQ:SDGR | 43.00M | -3.5% | 10.2% | N/A |
Continue your OMDA research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.